Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hyperlipoproteinemias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    June 2021
  1. KUEHN BM
    Evinacumab Approval Adds a New Option for Homozygous Familial Hypercholesterolemia With a Hefty Price Tag.
    Circulation. 2021;143:2494-2496.
    PubMed    


    March 2021

  2. Correction to: Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.
    Circulation. 2021;143:e799.
    PubMed    


    November 2020
  3. KULLO IJ
    Familial Hypercholesterolemia: A Reportable Disorder.
    Circulation. 2020;142:1999-2001.
    PubMed    


    October 2020
  4. MSZAR R, Nasir K, Santos RD
    Coronary Artery Calcification in Familial Hypercholesterolemia: An Opportunity for Risk Assessment and Shared Decision Making With the Power of Zero?
    Circulation. 2020;142:1405-1407.
    PubMed    


    June 2020
  5. KHERA AV, Hegele RA
    What Is Familial Hypercholesterolemia, and Why Does It Matter?
    Circulation. 2020;141:1760-1763.
    PubMed    


  6. HOVINGH GK, Lepor NE, Kallend D, Stoekenbroek RM, et al
    Inclisiran Durably Lowers Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin/Kexin Type 9 Expression in Homozygous Familial Hypercholesterolemia: The ORION-2 Pilot Study.
    Circulation. 2020;141:1829-1831.
    PubMed    


    May 2020
  7. HU P, Dharmayat KI, Stevens CAT, Sharabiani MTA, et al
    Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Circulation. 2020 May 29. doi: 10.1161/CIRCULATIONAHA.119.044795.
    PubMed    


    April 2020
  8. FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
    The Variety of Cardiovascular Presentations of COVID-19.
    Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
    PubMed    


    November 2019
  9. ZHAO H, Li Y, He L, Pu W, et al
    In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
    Circulation. 2019 Nov 29. doi: 10.1161/CIRCULATIONAHA.119.042476.
    PubMed     Abstract available


  10. JUKEMA JW, Zijlstra LE, Bhatt DL, Bittner VA, et al
    Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043826.
    PubMed    


  11. DAMASK A, Steg PG, Schwartz GG, Szarek M, et al
    Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044434.
    PubMed     Abstract available


    June 2019
  12. WILSON PWF, Polonsky TS, Miedema MD, Khera A, et al
    Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelin
    Circulation. 2019;139:e1144-e1161.
    PubMed     Abstract available


  13. GRUNDY SM, Stone NJ, Bailey AL, Beam C, et al
    2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2019;139:e1082-e1143.
    PubMed    


  14. KHERA A
    The New 2018 Cholesterol Guidelines.
    Circulation. 2019;139:2805-2808.
    PubMed    


  15. GRUNDY SM, Stone NJ, Bailey AL, Beam C, et al
    2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2019;139:e1046-e1081.
    PubMed    


    May 2019
  16. STEG PG, Szarek M, Bhatt DL, Bittner VA, et al
    Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038840.
    PubMed     Abstract available


    April 2019
  17. TZIAKAS DN, Chalikias G, Pavlaki M, Kareli D, et al
    Lysed Erythrocyte Membranes Promote Vascular Calcification.
    Circulation. 2019;139:2032-2048.
    PubMed     Abstract available


  18. WRIGHT AK, Kontopantelis E, Emsley R, Buchan IE, et al
    Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039100.
    PubMed     Abstract available


    November 2018
  19. KHERA AV, Chaffin M, Zekavat SM, Collins RL, et al
    Whole Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized with Early-Onset Myocardial Infarction.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035658.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: